SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)
| Valuation | |
|---|---|
| Market Cap ($M) | 309.08 |
| Enterprise Value ($M) | 185.33 |
| Book Value ($M) | 631.69 |
| Book Value / Share | 17.29 |
| Price / Book | 0.49 |
| NCAV ($M) | 453.49 |
| NCAV / Share | 12.41 |
| Price / NCAV | 0.68 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.19 |
| Return on Assets (ROA) | -0.18 |
| Return on Equity (ROE) | -0.20 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 14.80 |
| Current Ratio | 14.80 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 544.88 |
| Assets | 723.08 |
| Liabilities | 91.39 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | EcoR1 Capital, LLC | 4.40 | -17.28 | |
| 13G/A | BlackRock, Inc. | 10.60 | 0.00 | |
| 13D/A | Boxer Capital, LLC | 8.10 | 2.48 | |
| 13D/A | Boxer Asset Management Inc. | 0.00 | ||
| 13G | Tang Capital Management Llc | 6.60 | ||
| 13D/A | Ra Capital Management, L.p. | 9.99 | -17.16 | |
| 13G/A | Biotechnology Value Fund L P | 3.50 | -30.45 | |
| 13G/A | Vanguard Group Inc | 4.17 | -18.04 | |
| 13G/A | Millennium Management Llc | 2.70 | -53.73 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 209,970 | 854,170 | 24.58 | |
| 89,770 | 514,416 | 17.45 | |
| 58,210 | 265,220 | 21.95 | |
| 45,994 | 285,879 | 16.09 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| IOVA – Iovance Biotherapeutics, Inc. | IPA – ImmunoPrecise Antibodies Ltd. |
| IRON – Disc Medicine, Inc. | IVVD – Invivyd, Inc. |
| IXHL – Incannex Healthcare Inc. |
Financial data and stock pages provided by
Fintel.io